Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma. Li A, Sultan D, Heo GS, Detering L, et al. J Nucl Med 2026 Mar 12:jnumed.125.271601. doi: 10.2967/jnumed.125.271601.

Read + Share

Amedeo Smart

Independent Medical Education

Li A, Sultan D, Heo GS, Detering L, et al. Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma. J Nucl Med 2026 Mar 12:jnumed.125.271601. doi: 10.2967/jnumed.125.271601.
PMID: 41819828